Eli Lilly and CompanyLLYNYSE
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+31.7%
5Y CAGR+21.6%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+31.7%/yr
vs +7.3%/yr prior
5Y CAGR
+21.6%/yr
Recent acceleration
Acceleration
+24.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $65.18B | +44.7% |
| 2024 | $45.04B | +32.0% |
| 2023 | $34.12B | +19.6% |
| 2022 | $28.54B | +0.8% |
| 2021 | $28.32B | +15.4% |
| 2020 | $24.54B | +9.9% |
| 2019 | $22.32B | +3.8% |
| 2018 | $21.49B | +7.6% |
| 2017 | $19.97B | -5.9% |
| 2016 | $21.22B | - |